Ruxolitinib Combined With Dexamethasone for HLH
Clinical trial NCT03795909 · UNKNOWN
Trial details
- NCT number
- NCT03795909
- Sponsor
- Capital Research Institute of Pediatrics
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-01
- Primary completion
- 2020-03-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.